^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BZ019

i
Other names: BZ019, CD19-targeted Chimeric Antigen Receptor T Cells
Associations
Company:
Shanghai Cell Therapy Group
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations